Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
07 Feb 2023
07 Feb 2023
Historique:
entrez:
17
2
2023
pubmed:
18
2
2023
medline:
18
2
2023
Statut:
epublish
Résumé
Determining how high body-mass index (BMI) at different time points influences the risk of developing type two diabetes (T2D), and affects insulin secretion and insulin sensitivity, is critical. By estimating childhood BMI in 441,761 individuals in the UK Biobank, we identified which genetic variants had larger effects on adulthood BMI than on childhood BMI, and vice-versa. All genome-wide significant genetic variants were then used to separate the independent genetic effects of high childhood BMI from high adulthood BMI on the risk of T2D and insulin related phenotypes using Mendelian randomisation and studies of T2D, and oral and intravenous measures of insulin secretion and sensitivity. We found that a 1.s.d. (= 1.97kg/m High BMI in adulthood is associated with higher risk of type two diabetes, coupled with lower insulin sensitivity and secretion.Richardson et al [2020] used genetics to show that high BMI in childhood does not appear to increase the risk of type diabetes independently from its effect on adult BMI.We asked: does high childhood BMI affect insulin related traits such as fasting glucose and insulin sensitivity, independently of adulthood BMI?We used genetics to show that high childhood BMI has a protective effect on seven insulin sensitivity and secretion traits, including fasting glucose and measures of insulin sensitivity and secretion, independently of adulthood BMI.Our work has the potential to turn conventional understanding on its head - high BMI in childhood improves insulin sensitivity (when adjusting for knock on effects to high adult BMI) and opens up important questions about plasticity in childhood and compensatory mechanisms.
Identifiants
pubmed: 36798216
doi: 10.1101/2023.02.03.23285420
pmc: PMC9934707
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/T002239/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R56 DK062370
Pays : United States
Organisme : Medical Research Council
ID : MR/W014548/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK062370
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK062370
Pays : United States
Organisme : British Heart Foundation
ID : PG/17/21/32844
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Commentaires et corrections
Type : UpdateIn
Références
N Engl J Med. 2018 Apr 05;378(14):1302-1312
pubmed: 29617589
Science. 2007 May 11;316(5826):889-94
pubmed: 17434869
Pediatrics. 2005 Aug;116(2):473-80
pubmed: 16061606
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
BMJ. 2020 May 06;369:m1203
pubmed: 32376654
Nat Genet. 2021 Jul;53(7):1097-1103
pubmed: 34017140
PLoS Genet. 2022 Jul 18;18(7):e1010290
pubmed: 35849575
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
PLoS Genet. 2017 Nov 17;13(11):e1007081
pubmed: 29149188
Mol Psychiatry. 2021 Nov;26(11):6305-6316
pubmed: 34099873
FASEB J. 2010 Jan;24(1):326-31
pubmed: 19741173
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
PLoS Genet. 2014 Apr 03;10(4):e1004235
pubmed: 24699409
Hum Mol Genet. 2016 Jan 15;25(2):389-403
pubmed: 26604143
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:32-42
pubmed: 18834431
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Commun. 2021 Jan 5;12(1):24
pubmed: 33402679